Yan Xu

Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.

Li Li, Haiyan Tan, Graham Casey, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Understanding the Molecular Determinants of Substrate and Inhibitor Specificities in the Carbapenemase KPC-2: Exploring the Roles of Arg220 and Glu276

Robert A. Bonomo, R. Bonomo, Yan Xu, 2012, Antimicrobial Agents and Chemotherapy.

RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells

Zhefu Ma, Shunqiang Li, Hongbing Wang, 2018, Clinical Cancer Research.

Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations

Liem Nguyen, Robert A. Bonomo, Saugata Hazra, 2013, Antimicrobial Agents and Chemotherapy.